Benkert, T. F., Dietz, L., Hartmann, E. M., Leich, E., Rosenwald, A., Serfling, E., . . . Berberich-Siebelt, F. (2012). Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis. Public Library of Science.
Chicago Style CitationBenkert, Thomas F., Lena Dietz, Elena M. Hartmann, Ellen Leich, Andreas Rosenwald, Edgar Serfling, Mathias Buttmann, i Friederike Berberich-Siebelt. Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients With Multiple Sclerosis. Public Library of Science, 2012.
Cita MLABenkert, Thomas F., et al. Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients With Multiple Sclerosis. Public Library of Science, 2012.